Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Prokarium Ltd
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 years
Histologically documented recurrence of NMIBC
BCG unresponsive (BCG naïve patients may be enrolled if they have received at least 1 line of adequate intravesical standard of care (SOC) treatment and are either not candidates for BCG or do not have access to BCG (e.g., BCG shortage))
Eastern Cooperative Oncology Group Performance Status 0-1
Adequate organ and marrow function
Highly effective contraception if risk of conception exists.
You may not be if
Received treatment with any local or systemic antineoplastic therapy within 3 weeks or 5× the plasma half-life prior to first dose of ZH9
Major surgery or radiation within the 3 weeks prior to Screening (TURBT is not considered major surgery)
Concurrent urinary tract infection or history of clinically significant polyuria
Symptoms consistent with typhoid
Evidence of infection within 2 weeks of the first dose of ZH9
